Sagimet Biosciences updates investor presentation on metabolic dysfunction therapeutics

Sagimet Biosciences Inc.

Company furnished an updated slide deck dated July 2026 for use in investor meetings.
Presentation titled 'Targeting Metabolic Dysfunction with Novel Therapeutics'.
No specific financial or clinical data disclosed in the filing or exhibit.
Update is routine; no material changes to business or guidance provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.